Another study just published regarding use of CSL112. It shows that it is probably OK to take CSL112 when also taking Statins, which one would expect to be a common situation.
https://pubmed.ncbi.nlm.nih.gov/33932462/
"These data support concomitant use of CSL112 with alirocumab and/or atorvastatin with no anticipated negative impact on liver safety and TK."
So looks like lots of pieces of data coming together for the eventual release of the drug.
building the case for csl112, page-8
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$276.02 |
Change
0.215(0.08%) |
Mkt cap ! $133.4B | |||
| Open | High | Low | Value | Volume |
| $276.76 | $277.00 | $275.48 | $14.97M | 54.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31 | $276.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $276.03 | 103 | 10 |
View Market Depth
| Last trade - 10.58am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$276.06 |
Change
0.215 ( 0.07 %) |
||||
| Open | High | Low | Volume | ||
| $276.39 | $277.00 | $275.45 | 43746 | ||
| Last updated 11.16am 06/05/2024 ? | |||||
| CSL (ASX) Chart |